{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:09:56Z","timestamp":1792602596082,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12 HS023011"],"award-info":[{"award-number":["K12 HS023011"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","award":["UL1TR000150"],"award-info":[{"award-number":["UL1TR000150"]}],"id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.anai.2021.03.019","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T11:51:19Z","timestamp":1617364279000},"page":"83-90.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Clinical phenotyping of atopic dermatitis using combined itch and lesional severity"],"prefix":"10.1016","volume":"127","author":[{"given":"Raj","family":"Chovatiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2021.03.019_bib0001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaad.2018.09.035","article-title":"A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics","volume":"80","author":"Yew","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.anai.2017.09.076","article-title":"Burden of skin pain in atopic dermatitis","volume":"119","author":"Vakharia","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.03.019_bib0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/DER.0000000000000161","article-title":"Burden of sleep and fatigue in US adults with atopic dermatitis","volume":"27","author":"Yu","year":"2016","journal-title":"Dermatitis"},{"issue":"8","key":"10.1016\/j.anai.2021.03.019_bib0004","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.jaip.2019.05.055","article-title":"Pain is a common and burdensome symptom of atopic dermatitis in United States adults","volume":"7","author":"Silverberg","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/DER.0000000000000401","article-title":"Sleep disturbance and sleep-related impairment in adults with atopic dermatitis: a cross-sectional study","volume":"29","author":"Li","year":"2018","journal-title":"Dermatitis"},{"issue":"1","key":"10.1016\/j.anai.2021.03.019_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/jid.2014.325","article-title":"Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study","volume":"135","author":"Silverberg","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0007","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.03.019_bib0008","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data","volume":"18","author":"Kwa","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0009","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.anai.2018.07.042","article-title":"Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.03.019_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anai.2019.06.002","article-title":"Depression and psychological distress in US adults with atopic dermatitis","volume":"123","author":"Cheng","year":"2019","journal-title":"Ann Allergy asthma immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.03.019_bib0011","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clindermatol.2017.03.008","article-title":"Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders","volume":"35","author":"Silverberg","year":"2017","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0012","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bjd.17683","article-title":"Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults","volume":"181","author":"Silverberg","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0013","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic dermatitis in America Study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population","volume":"139","author":"Chiesa Fuxench","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2021.03.019_bib0014","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaip.2018.11.043","article-title":"Health utility scores of atopic dermatitis in US adults","volume":"7","author":"Silverberg","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma immunol"},{"issue":"7","key":"10.1016\/j.anai.2021.03.019_bib0016","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/jdv.15574","article-title":"Distribution of atopic dermatitis lesions in United States adults","volume":"33","author":"Silverberg","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.anai.2021.03.019_bib0017","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/13548500601073928","article-title":"Illness perception in individuals with atopic dermatitis","volume":"12","author":"Wittkowski","year":"2007","journal-title":"Psychol Health Med"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0018","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2133.2008.08941.x","article-title":"Itch characteristics in atopic dermatitis: results of a web-based questionnaire","volume":"160","author":"Dawn","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0019","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","article-title":"Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults","volume":"74","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0020","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2016.07.016","article-title":"Research letter: Impact of pruritus on quality of life-a systematic review","volume":"75","author":"Kantor","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0021","first-page":"44","article-title":"Diagnostic features of atopic eczema","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Dermatovener (Stockholm)"},{"issue":"2","key":"10.1016\/j.anai.2021.03.019_bib0022","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/all.13309","article-title":"Validation of patient-reported global severity of atopic dermatitis in adults","volume":"73","author":"Vakharia","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0023","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjd.18978","article-title":"Measurement properties of the Patient-Reported Outcomes Information System (PROMIS) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis","volume":"183","author":"Silverberg","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2021.03.019_bib0024","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bjd.18657","article-title":"Validation of five patient-reported outcomes for atopic dermatitis severity in adults","volume":"182","author":"Silverberg","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0025","first-page":"997","article-title":"The dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0026","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.17243","article-title":"Measurement properties of three assessments of burden used in atopic dermatitis in adults","volume":"180","author":"Patel","year":"2019","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.anai.2021.03.019_bib0027","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jid.2019.03.1152","article-title":"Validation and interpretation of short Form 12 and comparison with dermatology life quality index in atopic dermatitis in adults","volume":"139","author":"Silverberg","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0028","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.anai.2018.07.004","article-title":"Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2021.03.019_bib0029","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.anai.2021.03.019_bib0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11136-009-9489-8","article-title":"Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample","volume":"18","author":"Revicki","year":"2009","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0031","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jid.2019.08.452","article-title":"Development, validation, and interpretation of the PROMIS itch questionnaire: a patient-reported outcome measure for the quality of life impact of itch","volume":"140","author":"Silverberg","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0032","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaad.2019.11.057","article-title":"Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitis","volume":"82","author":"Silverberg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0033","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.anai.2020.06.014","article-title":"Association of itch triggers with atopic dermatitis severity and course in adults","volume":"125","author":"Silverberg","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2021.03.019_bib0034","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Lee B, Lei D, et\u00a0al. Measurement properties of patient health Questionnaire 9 and patient health Questionnaire 2 in adult patients with atopic dermatitis [e-pub ahead of print]. Dermatitis. doi:10.1097\/DER.0000000000000653, Accessed February 9, 2021.","DOI":"10.1097\/DER.0000000000000653"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2020.04.104","article-title":"The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): the development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis","volume":"83","author":"Simpson","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0036","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bjd.15641","article-title":"Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis","volume":"177","author":"Chopra","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0037","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clindermatol.2018.05.012","article-title":"Assessing the severity of atopic dermatitis in clinical trials and practice","volume":"36","author":"Chopra","year":"2018","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2021.03.019_bib0038","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jaci.2017.04.052","article-title":"Relationship between EASI and SCORAD severity assessments for atopic dermatitis","volume":"140","author":"Chopra","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.03.019_bib0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis","volume":"10","author":"Hanifin","year":"2001","journal-title":"EASI Evaluator Group. Exp Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2021.03.019_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.anai.2021.03.019_bib0041","series-title":"Statistics Without Maths for Psychology","author":"Dancey","year":"2007"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0042","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mai.2003.174","article-title":"Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure","volume":"111","author":"Bender","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0043","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/bjd.18920","article-title":"Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitis","volume":"183","author":"Lei","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2021.03.019_bib0044","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.anai.2017.10.039","article-title":"Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape","volume":"120","author":"Boguniewicz","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2 Pt 1","key":"10.1016\/j.anai.2021.03.019_bib0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0190-9622(95)90128-0","article-title":"London-born black Caribbean children are at increased risk of atopic dermatitis","volume":"32","author":"Williams","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0046","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2133.1961.tb14988.x","article-title":"Atopic eczema in European and Negro West Indian infants in London","volume":"73","author":"DAVIS","year":"1961","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/DER.0000000000000034","article-title":"Associations of childhood eczema severity: a US population-based study","volume":"25","author":"Silverberg","year":"2014","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0048","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.anai.2018.11.015","article-title":"Racial differences in atopic dermatitis","volume":"122","author":"Brunner","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.03.019_bib0049","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.clindermatol.2018.05.011","article-title":"Patient-reported outcomes and quality of life measures in atopic dermatitis","volume":"36","author":"Vakharia","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.anai.2021.03.019_bib0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.anai.2020.07.005","article-title":"A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice","volume":"125","author":"Hong","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.03.019_bib0051","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.det.2017.02.007","article-title":"Long-term treatment of atopic dermatitis","volume":"35","author":"Prezzano","year":"2017","journal-title":"Dermatol Clin"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:55Z","timestamp":1761053215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1081120621002209"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.03.019","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical phenotyping of atopic dermatitis using combined itch and lesional severity","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}